Proinflammatory cytokines play a key role in the pathophysiology of muscle atrophy. In addition, n3 polyunsaturated fatty acids (PUFAs) exert an inhibitory effect on proinflammatory cytokines affecting many inflammatory diseases. We hypothesized that dietary supplementation of fish oil could attenuate lipopolysaccharide (LPS)-induced muscle atrophy. Weanling pigs were used in a 2 3 2 factorial design and the main factors included diet (5% corn oil or 5% fish oil) and immunological challenge (LPS or saline). Fish oil decreased the mRNA abundance of muscle atrophy F-box (MAFbx) and muscle RING finger 1 in gastrocnemius and LD muscles. Moreover, fish oil reduced the plasma tumor necrosis factor (TNF) a, muscle TNFa, and prostaglandin E 2 concentrations, and muscle TNFa and cyclooxygenase 2 (COX2) mRNA abundance. Finally, fish oil downregulated the mRNA abundance of muscle toll-like receptor (TLR4) and its downstream signaling molecules [myeloid differentiation factor 88 (MyD88), TNFa receptor-associated factor 6 (TRAF6), and NF-kB p65], and nucleotide-binding oligomerization domain protein (NOD1), NOD2, and their adaptor molecule [receptor-interacting serine/threonine-protein kinase 2 (RIPK2)]. These results indicate fish oil may suppress muscle proinflammatory cytokine production via regulation of TLR and NOD signaling pathways and therefore improve muscle protein mass, possibly through maintenance of Akt/FOXO signaling.
Introduction
Skeletal muscle, the most abundant tissue in the body, is involved in many important functions (1) . However, sepsis and inflammation lead to the rapid loss of muscle mass and myofibrillar proteins (muscle atrophy), which results in increased morbidity during acute illness (2) or poor quality of life (1) . Accumulating evidence suggests that proinflammatory cytokines play a critical role in the pathophysiology of muscle atrophy (3, 4) . Proinflammatory cytokines have been reported to promote muscle protein degradation (4, 5) . In addition, proinflammatory cytokines also induce muscle atrophy partially through alterations of the Akt/Forkhead Box O (FOXO) 7 /ubiquitin-proteasome proteolysis pathway (6) . Therefore, nutritional modulation aimed at suppressing the release of proinflammatory cytokines may potentially be beneficial in attenuating muscle atrophy during sepsis and inflammation.
Accumulating lines of literature indicate that n3 PUFAs such as EPA (20:5n3) and DHA (22:6n3) , which are mainly found in deep-sea fish, can dampen the inflammatory responses and exert protective effects on many inflammatory diseases, including rheumatoid arthritis, inflammatory bowel diseases, and asthma in animal disease models and human clinical trials (7) (8) (9) . The beneficial role of n3 PUFAs may be associated with their inhibitory roles on the overproduction of proinflammatory cytokines (7, 9) . One of the mechanisms for the antiinflammatory effect of n3 PUFAs is that they keep IkB (the inhibitory subunit of NFkB complex) bound to NFkB, preventing NFkB from translocating to the nucleus to induce transcription of proinflammatory cytokines (10) . In addition, n3 PUFAs might be effective in the treatment and prevention of muscle atrophy. Indeed, dietary n3 PUFAs improved muscle protein synthesis in older (11) and healthy young and middle-aged adults (12) . Furthermore, EPA may alleviate muscle atrophy in cancer (13) and sepsis (14) . However, the molecular mechanism(s) underlying this beneficial effect remain to be elucidated.
Pattern recognition receptors, such as transmembrane tolllike receptors (TLRs) and cytoplasmic nucleotide-binding oligomerization domain proteins (NODs), are key protein families that regulate innate and adaptive immune responses by recognition of conserved microbial structures, termed pathogen associated molecular patterns (PAMPs) (15, 16) . Skeletal muscles express multiple TLRs (4) and NODs (17) . Interaction of TLRs or NODs with their specific PAMPs triggers multiple downstream intracellular signals that result in the activation of NFkB (15) , which then induces expression of the inflammatory genes such as TNFa, IL-1b, and IL-6 (15) . Consequently, these cytokines suppress the muscle protein kinase Akt and enhance the activity of FOXO transcription factors and atrogenes (i.e., muscle atrophy-related ubiquitin ligases) involved in ubiquitinproteasome-dependent protein degradation, leading to muscle wasting (4) . Accordingly, we hypothesized that dietary supplementation of n3 PUFAs may suppress muscle proinflammatory cytokine production via regulation of the TLR and NOD signaling pathways and therefore protect against muscle atrophy, partially through maintenance of Akt/FOXO signaling. In the current experiment, Escherichia coli LPS, a potent endotoxin, was administrated to establish the model of endotoxemia (6) . In addition, we made use of a weaned piglet model, an excellent animal model for nutrition research of humans, especially child and adolescent with muscles undergoing rapid growth (18, 19) . Our objective was to evaluate whether fish oil (abundant in n3 PUFAs such as EPA and DHA) could alleviate muscle atrophy caused by LPS challenge and to elucidate its molecular mechanism(s).
Materials and Methods
Pig care and experimental design. All procedures were approved by the Animal Care and Use Committee of Hubei Province, China. Animals and experimental design were the same as previously described (20) . Briefly, a total of 24 weaned barrows (Duroc 3 Large White 3 Landrace; weaned at 21 6 1 d of age; 9.0 6 0.7 kg initial body weight) were acquired and individually caged. Pigs of the same gender were used for keeping animal uniformity. Pigs were randomly allotted to 1 of 2 diets [5% corn oil-supplemented diet (control) (n = 12) or fish oil-supplemented diet (n = 12)]. Menhaden fish oil and corn oil were obtained from Fujian Gaolong and Xiwang Food, respectively. The dietary formula and fatty acid composition were previously reported (20) .
Pigs were allowed ad libitum access to diets and water for 21 d before the LPS challenge. The experimental design was a randomized complete block before the LPS challenge and became a 2 3 2 factorial design after the LPS challenge. The main factors consisted of diet (5% corn oil or 5% fish oil diets) and immunological challenge (LPS or saline). On d 21, one half of the pigs (n = 6) in each dietary treatment received an i.p. injection of either E. coli LPS (E. coli serotype 055: B5, Sigma Chemical) at 100 mg/kg body weight or the same amount of sterile saline solution. The LPS dose was chosen according to our previous study (21) (22) (23) . After injection with LPS or sterile saline solution, all pigs were deprived of feed until slaughter in order to exclude the possible effects of LPS-induced food intake reduction on variables in blood and muscle. The pigs were allowed ad libitum access to water.
Before (0 h) or at 2 and 4 h after administration of LPS or sterile saline solution, blood samples were obtained from the anterior vena cava via venipuncture and centrifuged (3500 3 g for 10 min) to collect plasma. Plasma was stored at -80°C for further analyses. Following blood collection at 4 h, all pigs were killed. The gastrocnemius and longissimus dorsi (LD) muscles were collected, frozen immediately in liquid nitrogen, and then stored at 280°C for subsequent analysis. The frozen muscle samples were weighed, homogenized, and centrifuged to collect the supernatant for analysis of TNFa and PGE 2 . Previous research has shown that, within 3-6 h postinjection, LPS caused tissue injury (22) (23) (24) (25) (26) and increased tissue proinflammatory cytokine mRNA (22, 24, 25) or protein expressions (23, 26) . In addition, TLR4 was also upregulated in mRNA (27) and protein (23, 27) during this timeframe. Therefore, we chose the time point of 4 h following LPS or saline injection for experimental measurements in muscles.
Muscle fatty acid composition. The fatty acid profile of total fat in muscles was determined according to the method of Nieto et al. (28) .
Glucose, urea nitrogen, insulin and TNFa concentrations in plasma, and TNFa and PGE 2 concentrations in muscle. Plasma glucose and urea nitrogen were measured using a Hitachi 7060 Automatic Biochemical Analyzer (Hitachi). The concentrations of insulin, TNFa, and PGE 2 in plasma or muscle supernatant were determined as previously described (20, 21) .
Measurement of muscle DNA, RNA, and protein. Muscle DNA, RNA, and protein contents were determined according to the method of Liu et al. (22) .
Real-time PCR measurement. Total RNA isolation, quantification, cDNA synthesis, and real-time PCR were carried out as previously described (20) . The primer pairs used are shown in Supplemental Table 1 . The expression of the target genes relative to the housekeeping gene (GAPDH) was analyzed by the 2 2DDCT method of Livak and Schmittgen (29) . Our results demonstrated that GAPDH did not display any variation among tissues and treatments. The relative mRNA expression level of each target gene was normalized to the group fed corn oil and injected with sterile saline solution.
Western blotting measurement. The methods for protein immunoblot analysis were the same as previously described (20) . Briefly, muscle samples were homogenized and centrifuged to collect the supernatants and then the protein contents were measured using the bicinchoninic acid reagent (20, 30 ). An equal amount of muscle proteins was loaded onto an SDS-PAGE, transferred to polyvinylidene difluoride membranes, and incubated with primary antibodies. The membranes were then incubated with the secondary antibody (20, 30) . Specific primary antibodies were purchased from Cell Signaling, including total Akt (tAkt; 1:1000; no. 9272), phosphorylated Akt (pAkt; serine 473 ; 1:1000; no. 9271), total FOXO 1 (tFOXO1; 1:1000; no. 9454), and phosphorylated FOXO 1 (pFOXO1; serine 256 ; 1:1000; no. 9461). Blots were developed using an Enhanced Chemiluminescence Western blotting kit (Amersham) and visualized using a Gene Genome bioimaging system. Bands were analyzed by densitometry using GeneTools software (Syngene). The phosphorylated forms of Akt and FOXO1 were normalized with their abundance, i.e., the total protein contents of Akt and FOXO1.
Statistical analysis. All data were analyzed by ANOVA using the GLM procedure of SAS appropriate for a 2 3 2 factorial design (SAS Institute).
The statistical model consisted of the effects of diet (corn oil vs. fish oil) and challenge (saline vs. LPS) and their interactions. Data were expressed as means 6 SEs. When a significant diet 3 LPS interaction or a trend for diet 3 LPS interaction occurred, post hoc testing was performed using BonferroniÕs multiple comparison tests. When variances were heterogeneous, nonparametric ANOVA was conducted. Differences were considered significant when P # 0.05. Instances in which 0.05 < P < 0.10 were discussed as trends.
Results
Muscle fatty acid composition after 4-h LPS challenge. The pigs injected with LPS had a lower proportion of palmitoleic acid (16:1n7) in gastrocnemius muscle (P < 0.05) and tended to have a higher proportion of palmitic acid (16:0) (P = 0.07) and a lower proportion of arachidonic acid (20:4n6) (P = 0.08) in LD muscle compared with pigs treated with saline ( Table 1) . Except for stearic acid (18:0) in LD muscle, no diet 3 LPS interaction was found for the other fatty acids. Muscle fatty acid compositions mostly mirrored the dietary fatty acid composition, which was previously reported (20) . Compared with pigs receiving corn oil, pigs receiving fish oil had higher proportions of myristic acid (14:0), palmitic acid, palmitoleic acid, stearic acid, EPA, DHA, lignoceric acid (24:0), and total n3 PUFAs in gastrocnemius and LD muscles (P < 0.05). They also had lower proportions of linoleic acid (18:2n6), arachidonic acid, total n6 PUFAs, and an n6:n3 ratio in gastrocnemius and LD muscles (P < 0.05). Fish oil did not affect the proportion of oleic acid (18:1n9) relative to corn oil.
Plasma glucose, urea nitrogen, insulin, and TNFa before (0 h) and after 2-and 4-h LPS challenge. Plasma glucose, urea nitrogen, and TNFa did not differ among the 4 treatments at 0 h (pre-challenge) ( Table 2 ). The pigs receiving fish oil had a higher plasma insulin concentration at 0 h compared with those receiving corn oil (P < 0.05). Relative to pigs treated with saline, pigs treated with LPS had a higher urea nitrogen concentration at 2 h postinjection (P < 0.05), a higher TNFa concentration at 2 and 4 h postinjection (P < 0.05), and lower glucose and insulin concentrations at 2 and 4 h postinjection (P < 0.05). No diet 3 LPS interaction was found for insulin at 2 h postinjection or urea nitrogen and insulin concentrations at 4 h postinjection. However, the pigs receiving fish oil had higher insulin concentrations at 2 and 4 h postinjection (P < 0.05) and a lower urea nitrogen concentration at 4 h postinjection (P < 0.05) than pigs receiving corn oil. There was a diet 3 LPS interaction observed for urea nitrogen at 2 h postinjection (P = 0.001) and TNFa at 4 h postinjection (P < 0.05) and a trend for a diet 3 LPS interaction for TNFa at 2 h postinjection (P = 0.06). The responses of these variables to the LPS treatment were lower in pigs fed fish oil 1 Values are means 6 SEs, n = 6 (1 pig/pen). Labeled means in a row without a common letter differ, P , 0.05. LD, longissimus dorsi. 2 The muscle fatty acid profiles from 4:0 to 24:1n9 were analyzed in duplicate. Only the major fatty acids are listed. 3 Total n6 PUFAs and total n3 PUFAs corresponded to the sum of all the n6 or n3 PUFAs detected.
Fish oil alters Akt/FOXO, TLR4, and NOD signaling 1333 compared with the LPS-treated pigs fed corn oil. However, diet had no effect on these variables in saline-treated pigs.
Muscle protein, DNA, and RNA contents after 4-h LPS challenge. No diet 3 LPS interaction was observed for protein, DNA, and RNA in gastrocnemius and LD muscles ( Table 3) . Pigs treated with LPS had a lower RNA concentration in gastrocnemius muscle and a lower protein:DNA ratio in LD muscle compared with pigs treated with saline (P < 0.05). Compared with pigs receiving the corn oil diet, pigs receiving the fish oil diet had a higher protein concentration and protein:DNA ratio in gastrocnemius muscle (P < 0.05). They also had higher protein and RNA concentrations and RNA:DNA and protein:DNA ratios in LD muscle (P < 0.05). Neither diet nor LPS treatment affected DNA content.
mRNA expression of Akt1/FOXO signaling and their target genes after 4-h LPS challenge. Relative to pigs treated with saline, pigs treated with LPS had a lower mRNA abundance of Akt1 in LD muscle and higher mRNA abundance of FOXO1 in gastrocnemius and LD muscles (P < 0.001). The muscle atrophy F-box (MAFbx) and muscle RING finger 1 (MuRF1) in gastrocnemius muscle (P < 0.05) and MuRF1 in LD muscle (P < 0.001) were also higher from pigs treated with LPS than those treated with saline ( Table 4) . No diet 3 LPS interaction was observed for FOXO1, FOXO4, and MAFbx in gastrocnemius muscle and FOXO1 in LD muscle. However, the pigs fed the fish oil diet had a lower mRNA abundance of FOXO1, FOXO4, and MAFbx in gastrocnemius muscle (P # 0.05) and tended to have lower mRNA abundance of FOXO1 in LD muscle (P = 0.06). There was a diet 3 LPS interaction observed for MuRF1 in gastrocnemius and LD muscles (P < 0.05). The responses of these variables to LPS were lower in pigs fed the diet with fish oil than the pigs fed the diet with corn oil. For pigs injected with saline, diet did not affect these variables. A diet 3 LPS interaction was also found for MAFbx in LD muscle (P = 0.05) such that fish oil decreased the mRNA abundance of MAFbx in LD muscle in pigs injected with saline; however, diet did not affect this variable in LPS-injected pigs. Protein phosphorylation and abundance of Akt and FOXO1 after 4-h LPS challenge. There was no diet 3 LPS interaction observed for the ratio of pAkt:tAkt, tAkt, the ratio of pFOXO1: tFOXO1, and tFOXO1 ( Fig. 1 ; Table 5 ). Pigs treated with LPS had a lower ratio of pAkt:tAkt in gastrocnemius and LD muscles than pigs injected with saline (P < 0.05). Challenge with LPS did not influence the ratio of pFOXO1:tFOXO1 in gastrocnemius and LD muscles. The pigs receiving fish oil had a higher ratio of pAkt:tAkt in gastrocnemius muscle (P = 0.001) and a higher ratio of pFOXO1:tFOXO1 in gastrocnemius (P < 0.05) and LD muscle (P = 0.05). Neither diet nor LPS affected tAkt and tFOXO1 in gastrocnemius and LD muscles.
Muscle TNFa and PGE 2 concentrations and TNFa and cyclooxygenase 2 mRNA expression after 4-h LPS challenge. No diet 3 LPS interaction was observed for muscle TNFa and PGE 2 concentrations ( Table 6 ). Pigs treated with LPS had higher concentrations of TNFa and PGE 2 in LD muscle than pigs treated with saline (P < 0.05). Pigs receiving the fish oil diet had lower TNFa and PGE 2 concentrations in gastrocnemius and a lower TNFa concentration in LD muscle compared with pigs fed the diet with corn oil (P < 0.05). The LPS-injected pigs had higher mRNA abundances of TNFa and cyclooxygenase 2 (COX2) in gastrocnemius and LD muscles relative to the saline-injected pigs (P < 0.05) ( Table 7) . A diet 3 LPS interaction was found for TNFa in gastrocnemius muscle (P < 0.05). The pigs fed the fish oil diet had lower TNFa mRNA abundance in gastrocnemius compared with pigs fed corn oil diet among LPS-challenged pigs. However, there was no difference between the fish oil and corn oil diets in the salinetreated pigs. There was no diet 3 LPS interaction observed for muscle COX2. The pigs receiving the fish oil diet had lower COX2 mRNA abundance in LD muscle compared with pigs fed the corn oil diet (P < 0.05).
mRNA abundance of TLR4 and NODs and their downstream signals after 4-h LPS challenge. Relative to pigs injected with saline, the pigs subjected to the LPS challenge had a higher mRNA abundance (Table 7) of TLR4, myeloid differentiation factor 88 (MyD88), NOD2, and receptor-interacting serine/ threonine-protein kinase 2 (RIPK2) in gastrocnemius muscle (P < 0.01), and TLR4, MyD88, TNFa receptor-associated factor 6 (TRAF6), NOD2, RIPK2, and NF-kB p65 in LD muscle (P < 0.05). A diet 3 LPS interaction was found for TLR4, MyD88, TRAF6, NOD1, NOD2, RIPK2, and NF-kB p65 in gastrocnemius muscle (P < 0.05) and TLR4 and NOD2 in LD muscle (P < 0.05). The responses of these variables to the LPS challenge were lower in pigs fed the diet with fish oil than in the pigs fed the diet with corn oil. However, diet did not affect these variables in pigs injected with saline. No diet 3 LPS interaction was found for TRAF6 in LD muscle. However, the pigs receiving fish oil had a lower TRAF6 mRNA abundance in LD muscle relative to pigs receiving corn oil. Neither diet nor LPS influenced interleukin-1 receptor-associated kinase 1 (IRAK1) mRNA abundance.
Discussion
Our previous study showed that dietary treatment with 5% fish oil attenuated LPS-induced intestinal inflammation and improved intestinal integrity in a piglet model (20) . In this study, we extended it into the muscle tissue to explore the effect of fish oil on muscle atrophy after the LPS challenge using the same animals. Similar to the data of fatty acid profile of total fat in the intestine (20) , EPA, DHA, and total n3 PUFAs were enriched in total fat of gastrocnemius and LD muscles through 5% fish oil supplementation. Bergeron et al. (31) also reported that n3 PUFA supplementation resulted in increased proportions of EPA, DHA, and total n3 PUFAs and decreased proportions of linoleic acid, arachidonic acid, and total n6 PUFAs in total membrane phospholipids of LD muscle in neonatal piglets. Compared with the data in young piglets, fish oil-induced alterations in the muscle n3 PUFA concentration in adult pigs are similar but less pronounced (32) . Similar to the results in pigs, dietary n3 PUFA supplementation also resulted in enrichment of EPA, DHA, and n3 PUFAs in skeletal muscle phospholipids and TGs in humans (12, 33) .
Muscle atrophy represents a net loss of muscle protein, which is generally associated with excessive muscle protein degradation (34) . Plasma urea nitrogen is an indirect index to reflect muscle protein degradation and is negatively correlated with muscle growth (35) . In our study, LPS increased the plasma urea nitrogen concentration at 2 h after LPS challenge, whereas fish oil decreased it at 2 and 4 h after LPS challenge, suggesting that fish oil probably attenuated LPS-induced muscle atrophy by protecting muscle protein from degradation. Muscle protein, RNA, and DNA concentrations are also important indicators for muscle mass or muscle protein metabolism (12) . The protein: DNA ratio is a sensitive measure of muscle protein mass (6). The RNA:DNA ratio indicates the cell capacity for protein synthesis (12, 30) . In the current study, the LPS challenge decreased the protein:DNA ratio in LD muscle, suggesting that LPS could cause muscle atrophy. Independent of LPS challenge, fish oil increased the protein:DNA ratio in gastrocnemius and LD muscles, which indicates that fish oil increased muscle protein mass both before and after LPS challenge. Furthermore, independent of LPS challenge, fish oil increased protein and RNA concentrations and the RNA:DNA ratio in LD muscle as well as the protein concentration in gastrocnemius muscle, suggesting that fish oil stimulated the growth of muscle both before and after the LPS challenge. Similarly, Smith et al. (12) reported that the protein concentration and the protein:DNA ratio in muscle were greater in healthy young and middle-aged adults after n3 PUFA supplementation. Moreover, preservation of lean body mass by EPA treatment was observed in patients with unresectable pancreatic cancer (36) and with cancer cachexia (37) . Increased muscle protein breakdown during sepsis is considered to be primarily mediated by the ubiquitin-proteasome pathway (UPP) (6) . Among UPP, the E3 ubiquitin ligases MAFbx and MuRF1 are considered to be the key regulators of muscle protein degradation (38) . In the current experiment, consistent with the increased muscle protein mass, as indicated by the high protein: DNA ratio, fish oil significantly decreased mRNA expression of MAFbx and MuRF1 in gastrocnemius and LD muscles compared with corn oil. Our observations were supported by several researchers who reported that EPA attenuated muscle atrophy in cancer (13) , starvation (39), hyperthermia (40) , and sepsis (14) through downregulating key regulatory components of UPP, leading to a reduction in protein degradation. Thus, fish oil may increase muscle protein mass partially via inhibiting the UPP.
Akt, a key signaling protein, plays a critical role in insulin signaling transduction (2) . It induces protein synthesis and therefore results in skeletal muscle hypertrophy (2) . It also inhibits muscle protein degradation by phosphorylating and inactivating FOXO transcription factor family members (2). Phosphorylation and inactivation of FOXO result in transcriptional inhibition of FOXO target genes, i.e., MAFbx and MuRF1, and consequently a decrease in protein degradation (41) . In the current study, the LPS challenge decreased Akt1 mRNA expression in LD muscle and phosphorylation of Akt (the ratio of pAkt:tAkt) in gastrocnemius and LD muscles at 4 h following LPS challenge. Tarabees et al. (42) reported that Akt phosphorylation decreased in C2C12 myotubes at 5 and 30 min following LPS administration. Later, LPS had no effect on Akt phosphorylation at other time points. This suggests that the in vitro effect of LPS on Akt phosphorylation was rapid but transient compared with the in (43) reported that fish oil alleviated immobilization-induced soleus atrophy associated with attenuating the disturbances in activation of the Akt and p70 S6 kinase proteins and gene expression of muscle-specific E3 ubiquitin ligases (Mafbx and Murf1) in rats. In the current experiment, it is possible that the beneficial effects of fish oil on muscle atrophy are closely associated with inhibiting UPP through prevention of LPS-induced inhibition of Akt and activation of FOXO. It is well documented that increased levels of proinflammatory cytokines, both in the circulation and locally at the level of the skeletal muscle, play a critical role in the pathophysiology of muscle wasting (3). Proinflammatory cytokines have been reported to induce muscle atrophy partially through alterations of the Akt/FOXO/ubiquitin-proteasome proteolysis pathway (6) . Based on this, we hypothesized that fish oil exerted its protective role on muscle atrophy by attenuating muscle inflammatory response. In our study, consistent with improved muscle protein mass, fish oil reduced the TNFa concentration in plasma and LD and gastrocnemius muscles and the PGE 2 concentration in gastrocnemius muscle. Also, fish oil decreased the mRNA expression To explore the molecular mechanism(s) by which dietary supplementation of fish oil exerted an antiinflammatory role in muscle, we examined the roles of 2 pattern recognition receptors, including transmembrane TLR4 and cytoplasmic NODs. TLRs and NODs are 2 major forms of innate immune sensors, which play a central role in the detection of invading pathogens and regulation of innate and adaptive immune responses by recognizing PAMPs (15, 16) . Skeletal muscles express multiple TLRs (4) and NODs (17) , and their activation plays an important role in muscle wasting (4, 17) . The binding of TLRs or NODs with their specific PAMPs triggers multiple intracellular signaling pathways that result in the activation of NFkB, leading to expression and secretion of proinflammatory cytokines (15) . Consequently, these cytokines inhibit Akt and activate FOXO and atrogenes (such as MAFbx and MuRF1) involved in ubiquitinproteasome dependent protein degradation, resulting in muscle wasting (4, 17) . In the present experiment, we found that mRNA abundances of TLR4 and its downstream signals (MyD88 and TRAF6); NOD1, NOD2, and their downstream adaptor molecule (RIPK2) in gastrocnemius muscle; and TLR4, TRAF6, and NOD2 in longissimus muscle were reduced and the muscle TNFa concentration and mRNA abundance were simultaneously decreased in pigs receiving fish oil after the LPS treatment. Interestingly, fish oil and the LPS challenge had tissue-specific effects on NF-kB p65 mRNA expression. In gastrocnemius muscle, NF-kB p65 was upregulated by the LPS challenge and downregulated by fish oil. However, in small intestine, NF-kB p65 was not affected by LPS and fish oil (20) . Currently, the research about n3 PUFAs modulating TLR and NOD signaling in muscle tissues is very limited. Tishinsky et al. (45) reported that fish oil prevented a high-SFA diet-induced increase of TLR4 protein expression in soleus muscle of Sprague-Dawley rats. Our previous study showed that fish oil inhibited intestinal TLR4 and NOD2 signaling in weanling piglets subjected to LPS treatment (20) . In the current experiment, it is possible that the beneficial roles of fish oil supplementation on muscle protein mass are closely related to decreasing the expression of muscle proinflammatory cytokines through inhibiting the TLR4 and NOD signaling pathway.
In this study, dynamic changes occurred in proinflammatory gene expression, protein phosphorylation, or dephosphorylation of signaling molecules and protein synthesis or degradation in muscles after LPS challenge (42, 46, 47) . In addition, muscle atrophy is more of a long-term physiological response rather than a long-term acute response (36, 37) . So, measurements taken only at one time point (4 h) are probably not adequate to confirm the roles of signaling molecules and proinflammatory mediators in LPS-induced muscle atrophy. Thus, in future studies, sample collections at more time points (including later time points) are needed to better understand the dynamic interplay and the longterm effects of fish oil supplementation on muscle atrophy. In addition, measurements for muscle mass, protein degradation, and protein synthesis as well by a direct way are needed to further demonstrate the role of fish oil on muscle growth in future work.
In summary, dietary treatment of fish oil plays beneficial roles in enhancing muscle protein mass. It is possible that the beneficial roles of fish oil on the muscle are associated with preventing alteration of Akt/FOXO signaling by decreasing the expression of muscle proinflammatory cytokines via inhibition of TLR4 and NOD2 signaling pathways.
